The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
This is the second batch of vaccines rejected by South Africa, which turned away approximately one million AstraZeneca vaccines earlier in 2020. One study determined that those vaccines, sold to South Africa by the Serum Institute of India, provided little buffer against mild to moderate infections by the COVID-19 variant that is common in the country.
Above all were sub-Saharan lessons learned from HIV/AIDS living lab CONTAINMENT and ebola marketing, to date, not withstanding a decade-long BRICS offensive.
Now? Biden admin announces travel ban for South Africa and 7 other countries, citing new variant
Today the Biden Administration announced a Travel Ban on South Africa and 7 other African nations over the "New COVID Variant"Here was Joe Biden and Kamala Harris when Trump banned Travel: pic.twitter.com/NGVef2nkfS— Benny (@bennyjohnson) November 26, 2021
Today the Biden Administration announced a Travel Ban on South Africa and 7 other African nations over the "New COVID Variant"Here was Joe Biden and Kamala Harris when Trump banned Travel: pic.twitter.com/NGVef2nkfS
AstraZeneca was less effective against the Delta variant and India embargoes sending domestic manufactured vaccines overseas.
Outrageous Defense Production Act still blocking necessary raw materials for Indian Serum Institute COVID-19 vaccine production
"Vooma Vouchers": Over 60's to Get Paid for Vaccinating in SA
The vouchers are set to start going out from 4 November, though anyone in the right age group who gets vaccinated from 1 November should receive one. The vouchers are valid for 30 days, and persons will only receive a voucher for their first vaccine dose. Those coming for their second Pfizer dose, for example, are not eligible.
Covid-19 Vaccine detoxing: conversations on social media around ways to remove or "flush out" the vaccine from the body
HVTN 702 is part of a larger HIV vaccine research endeavor led by the Pox-Protein Public-Private Partnership, or P5 -- a diverse group of public and private organizations working to build on the RV144 trial. P5 members include NIAID, the Bill & Melinda Gates Foundation, and the South African Medical Research Council, which funded HVTN 702; the HIV Vaccine Trials Network (HVTN), headquartered at the Fred Hutchinson Cancer Research Center in Seattle, which conducted HVTN 702; Sanofi Pasteur and GSK, which provided study materials; and the U.S. Military HIV Research Program.
According to Balloux, the variant could have evolved during a "chronic infection of an immunocompromised person, possibly in an untreated HIV/AIDS patient"
by IdiotSavant - Sep 15 16 comments
by IdiotSavant - Sep 16 10 comments
by Oui - Sep 24 33 comments
by gmoke - Sep 24
by Cat - Sep 19 34 comments
by Oui - Sep 20 35 comments
by gmoke - Sep 12
by gmoke - Sep 5 14 comments
by Oui - Sep 2433 comments
by gmoke - Sep 24
by Oui - Sep 2320 comments
by Oui - Sep 22
by Oui - Sep 2035 comments
by Cat - Sep 1934 comments
by gmoke - Sep 19
by Oui - Sep 183 comments
by Oui - Sep 1615 comments
by IdiotSavant - Sep 1610 comments
by Oui - Sep 1524 comments
by Oui - Sep 159 comments
by IdiotSavant - Sep 1516 comments
by Oui - Sep 1420 comments
by Oui - Sep 149 comments
by Oui - Sep 1319 comments
by gmoke - Sep 12
by Oui - Sep 916 comments
by gmoke - Sep 514 comments
by Frank Schnittger - Sep 211 comments